These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7803894)

  • 1. Fluconazole-warfarin interaction.
    Baciewicz AM; Menke JJ; Bokar JA; Baud EB
    Ann Pharmacother; 1994 Sep; 28(9):1111. PubMed ID: 7803894
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraocular hemorrhages due to warfarin fluconazole drug interaction in a patient with presumed Candida endophthalmitis.
    Mootha VV; Schluter ML; Das A
    Arch Ophthalmol; 2002 Jan; 120(1):94-5. PubMed ID: 11786068
    [No Abstract]   [Full Text] [Related]  

  • 3. Spinal epidural haematoma as a result of warfarin/fluconazole drug interaction.
    Allison EJ; McKinney TJ; Langenberg JN
    Eur J Emerg Med; 2002 Jun; 9(2):175-7. PubMed ID: 12131644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding interaction between fluconazole and warfarin.
    de Filette J; Michiels V
    Lancet; 2018 Sep; 392(10153):e9. PubMed ID: 30303086
    [No Abstract]   [Full Text] [Related]  

  • 5. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
    Brown MC
    Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal and Gingival Bleeding During Aripiprazole but not Haloperidol Treatment.
    Hoşoğlu E; Bayram Ö; Hergüner S
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):950-951. PubMed ID: 26397016
    [No Abstract]   [Full Text] [Related]  

  • 7. Warfarin and epistaxis: should warfarin always be discontinued?
    Srinivasan V; Patel H; John DG; Worsley A
    Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):542-4. PubMed ID: 9466067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bleeding problems of a patient with hypothyroidism].
    Paul R
    Duodecim; 2002; 118(13):1361-3. PubMed ID: 12239881
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated severe thrombocytopenia and bleeding caused by piperacillin.
    Olivera E; Lakhani P; Watanakunakorn C
    Scand J Infect Dis; 1992; 24(6):815-7. PubMed ID: 1287819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing warfarin medication interactions: an interrupted time series evaluation.
    Feldstein AC; Smith DH; Perrin N; Yang X; Simon SR; Krall M; Sittig DF; Ditmer D; Platt R; Soumerai SB
    Arch Intern Med; 2006 May; 166(9):1009-15. PubMed ID: 16682575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction studies with fluconazole, a new triazole antifungal drug].
    Rieth H; Sauerbrey N
    Wien Med Wochenschr; 1989 Aug; 139(15-16):370-4. PubMed ID: 2556861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin and epistaxis--a case controlled study.
    Denholm SW; Maynard CA; Watson HG
    J Laryngol Otol; 1993 Mar; 107(3):195-6. PubMed ID: 8509693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions with fluconazole.
    Tett S; Carey D; Lee HS
    Med J Aust; 1992 Mar; 156(5):365. PubMed ID: 1588879
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring warfarin therapy.
    Beanland DR; Dorsey DA
    Am Fam Physician; 1999 Sep; 60(3):764, 766. PubMed ID: 10498107
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible interaction between warfarin and fluconazole.
    Gericke KR
    Pharmacotherapy; 1993; 13(5):508-9. PubMed ID: 8247921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.
    Smith J; Siddiq S; Dyer C; Rainsbury J; Kim D
    J Laryngol Otol; 2011 Jan; 125(1):38-42. PubMed ID: 20843406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition.
    Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF
    Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
    Black DJ; Kunze KL; Wienkers LC; Gidal BE; Seaton TL; McDonnell ND; Evans JS; Bauwens JE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):422-8. PubMed ID: 8801057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction.
    Kunze KL; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):429-35. PubMed ID: 8801058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions as cause of admission to hospital: admissions to ear, nose, and throat departments were not mentioned.
    Calder NJ; MacDonald D
    BMJ; 2004 Aug; 329(7463):460; author reply 460. PubMed ID: 15321919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.